Prelude Therapeutics Inc
2020 Q4 - 2025 Q4 (17 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 200 | 0.0% | 70,546 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 56 | 0.0% | 69,252 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 53 | 0.0% | 69,252 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 89 | 0.0% | 70,045 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 145 | 0.0% | 70,045 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 267 | 0.0% | 70,045 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 343 | 0.0% | 72,262 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 300 | 0.0% | 70,165 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 217 | 0.0% | 70,165 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 316 | 0.0% | 70,165 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 195 | 0.0% | 34,298 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 191 | 0.0% | 34,298 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 224 | 0.0% | 34,267 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 178 | 0.0% | 34,267 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 238 | 0.0% | 34,267 | 3/31/2022 |
| 2021 Q1 | 5/3/2021 | 239 | 0.0% | 5,516 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 378 | 0.0% | 5,289 | 12/31/2020 |